Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 457

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Effectiveness of a group B outer membrane vesicle meningococcal vaccine against gonorrhoea in New Zealand: a retrospective case-control study

Petousis-Harris, Helen, Paynter, Janine, Morgan, Jane, Saxton, Peter, McArdle, Barbara, Goodyear-Smith, Felicity, Black, Steven·2017·The Lancet

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s0140-6736(17)31449-6

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Research works printed but not linked: 33

  1. Newman, 2015, Global estimates of the prevalence and incidence of four curable sexually transmitted infections in 2012 based on systematic review and global reporting, PloS One, 10, e0143304, 10.1371/journal.pone.0143304 · DOI · Paper page
  2. Tramont, 1989, Gonococcal vaccines, Clin Microbiol Rev, 2, S74, 10.1128/CMR.2.Suppl.S74 · doi:10.1128/cmr.2.suppl.s74
  3. Lewis, 2014, Global resistance of Neisseria gonorrhoeae: when theory becomes reality, Curr Opin Infect Dis, 27, 62, 10.1097/QCO.0000000000000025 · doi:10.1097/qco.0000000000000025
  4. Bolan, 2012, The emerging threat of untreatable gonococcal infection, N Engl J Med, 366, 485, 10.1056/NEJMp1112456 · DOI · Paper page
  5. Edwards, 2016, Is gonococcal disease preventable? The importance of understanding immunity and pathogenesis in vaccine development, Crit Rev Microbiol, 2, 928, 10.3109/1040841X.2015.1105782 · DOI
  6. Eyre, 1909, The treatment of gononcoccus infections by vaccines, Lancet, 174, 76, 10.1016/S0140-6736(01)32510-2 · doi:10.1016/s0140-6736(01)32510-2
  7. Greenberg, 1971, Preliminary studies on the development of a gonococcal vaccine, Bull World Health Organ, 45, 531
  8. Greenberg, 1974, Gonococcal vaccine studies in Inuvik, Can J Public Health, 65, 29
  9. Boslego, 1991, Efficacy trial of a parenteral gonococcal pilus vaccine in men, Vaccine, 9, 154, 10.1016/0264-410X(91)90147-X · DOI · Paper page
  10. Zhu, 2011, Vaccines for gonorrhea: can we rise to the challenge?, Front Microbiol, 2, 124, 10.3389/fmicb.2011.00124 · DOI
  11. Jerse, 2014, Vaccines against gonorrhea: Current status and future challenges, Vaccine, 32, 1579, 10.1016/j.vaccine.2013.08.067 · DOI
  12. Pérez, 2009, Mucosal approaches in Neisseria vaccinology, VacciMonitor, 18, 53
  13. Whelan, 2016, Ecologic study of meningococcal b vaccine and Neisseria gonorrhoeae infection, Norway, Emerg Infect Dis, 22, 1137, 10.3201/eid2206.151093 · doi:10.3201/eid2206.151093
  14. Holst, 2013, Vaccines against meningococcal serogroup B disease containing outer membrane vesicles (OMV): lessons from past programs and implications for the future, Hum Vaccin Immunother, 9, 1241, 10.4161/hv.24129 · DOI · Paper page
  15. Tinsley, 1996, Analysis of the genetic differences between Neisseria meningitidis and Neisseria gonorrhoeae: Two closely related bacteria expressing two different pathogenicities, Proc Natl Acad Sci USA, 93, 11, 10.1073/pnas.93.20.11109 · DOI · Paper page
  16. Arnold, 2011, Effectiveness of a vaccination programme for an epidemic of meningococcal B in New Zealand, Vaccine, 29, 7100, 10.1016/j.vaccine.2011.06.120 · DOI
  17. Wind, 2016, Time to clearance of Chlamydia trachomatis RNA and DNA after treatment in patients coinfected with Neisseria gonorrhoeae—a prospective cohort study, BMC Infect Dis, 16, 554, 10.1186/s12879-016-1878-3 · doi:10.1186/s12879-016-1878-3
  18. Clarivet, 2014, Prevalence of Chlamydia trachomatis, Neisseria gonorrhoeae and Mycoplasma genitalium in asymptomatic patients under 30 years of age screened in a French sexually transmitted infections clinic, Eur J Dermatol, 24, 611, 10.1684/ejd.2014.2413 · doi:10.1684/ejd.2014.2413
  19. Weinberg, 2010, Vaccine epidemiology: efficacy, effectiveness, and the translational research roadmap, J Infect Dis, 201, 1607, 10.1086/652404 · DOI · Paper page
  20. Barnett, 2000, Holes in the safety net? Assessing the effects of targeted benefits upon the health care utilization of poor New Zealanders, Health Soc Care Community, 8, 159, 10.1046/j.1365-2524.2000.00239.x · doi:10.1046/j.1365-2524.2000.00239.x
  21. Manhart, 2004, Influence of study population on the identification of risk factors for sexually transmitted diseases using a case-control design: the example of gonorrhea, Am J Epidemiol, 160, 393, 10.1093/aje/kwh220 · DOI
  22. Virji, 2009, Pathogenic neisseriae: surface modulation, pathogenesis and infection control, Nat Rev Microbiol, 7, 274, 10.1038/nrmicro2097 · DOI · Paper page
  23. Rosenqvist, 1995, Human antibody responses to meningococcal outer membrane antigens after three doses of the Norwegian group B meningococcal vaccine, Infect Immun, 63, 4642, 10.1128/IAI.63.12.4642-4652.1995 · DOI · Paper page
  24. Davenport, 2003, Evidence for naturally acquired T cell mediated mucosal immunity to Neisseria meningitidis, J Immunol, 171, 4263, 10.4049/jimmunol.171.8.4263 · DOI
  25. Davenport, 2008, Mucosal immunity in healthy adults after parenteral vaccination with outer-membrane vesicles from Neisseria meningitidis serogroup B, J Infect Dis, 198, 731, 10.1086/590669 · DOI
  26. Jackson, 2011, Antibody persistence following MeNZB vaccination of adults and children and response to a fourth dose in toddlers, Arch Dis Childhood, 96, 744, 10.1136/adc.2009.180596 · DOI
  27. Bromhead, 2013, Comparison of the cobas 4800 CT/NG test with culture for detecting Neisseria gonorrhoeae in genital and nongenital specimens in a low-prevalence population in New Zealand, J Clin Microbiol, 51, 1505, 10.1128/JCM.03223-12 · doi:10.1128/jcm.03223-12
  28. Creighton, 2003, Co-infection with gonorrhoea and chlamydia: how much is there and what does it mean?, Int J STD AIDS, 14, 109, 10.1258/095646203321156872 · DOI
  29. Vonck, 2011, Chlamydial infection increases gonococcal colonization in a novel murine coinfection model, Infect Immun, 79, 1566, 10.1128/IAI.01155-10 · DOI
  30. Hedges, 1998, Cytokine and antibody responses in women infected with Neisseria gonorrhoeae: effects of concomitant infections, J Infect Dis, 178, 742, 10.1086/515372 · DOI
  31. Comanducci, 2002, NadA, a novel vaccine candidate of Neisseria meningitidis, J Exper Med, 195, 1445, 10.1084/jem.20020407 · DOI · Paper page
  32. Hadad, 2012, Novel meningococcal 4CMenB vaccine antigens—prevalence and polymorphisms of the encoding genes in Neisseria gonorrhoeae, APMIS, 120, 750, 10.1111/j.1600-0463.2012.02903.x · DOI
  33. Craig, 2015, The potential impact of vaccination on the prevalence of gonorrhea, Vaccine, 33, 4520, 10.1016/j.vaccine.2015.07.015 · doi:10.1016/j.vaccine.2015.07.015

Cited by

See all 457

Metadata

Authors
Petousis-Harris, H., Paynter, J., Morgan, J., Saxton, P., McArdle, B., Goodyear-Smith, F., & Black, S.
Venue
The Lancet
Publisher
Elsevier BV
Published
2017-09
Volume
390
Issue
10102
Pages
1603-1610
ISSN
  • 0099-5355 (ISSN-L)
  • 0140-6736
OpenAlex
W2735393008
Cited by
457
References
3
FWCI
32.05
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Effectiveness of a group B outer membrane vesicle meningococcal vaccine against gonorrhoea in New Zealand: a retrospective case-control study. https://app.cochat.ai/papers/10.1016/s0140-6736(17)31449-6
The paper
Petousis-Harris, H., Paynter, J., Morgan, J., Saxton, P., McArdle, B., Goodyear-Smith, F., & Black, S. (2017). Effectiveness of a group B outer membrane vesicle meningococcal vaccine against gonorrhoea in New Zealand: a retrospective case-control study. The Lancet. https://doi.org/10.1016/s0140-6736(17)31449-6

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.